Advanced search×

[Prevalence of male breast cancer in our department during a 5-year period].

Magy Seb 64(3):112-5 (2011) PMID 21672681

Male breast cancer is a rare entity. Statistics suggest the female:male ratio is100:1. Male breast cancer is most frequent in elderly patients, but it can occur at any age. The mean age of the onset of the disease is 10 years later in males compared to female patients. Here, the authors review the predisposing factors, main types of male breast cancer, diagnosis and treatment principals. Furthermore, they summarise data of five patients from their practice as regards diagnostic work-up, surgical and adjuvant treatments.

DOI: 10.1556/MaSeb.64.2011.3.2
Version: za2963e q8za5 q8zbe q8zc9 q8zda q8ze3 q8zf3 q8zg8

Similar articles you may find interesting…

  1. Impact of hormone replacement therapy use on mammographic screening outcomes.

    Cancer Causes Control (2013) PMID 23649232

    Increased risks of recall, biopsy rates, screen-detected, and interval cancers among HRT users have important implications for population-based breast cancer screening programs. Our findings support the concept that HRT use may increase the growth of preexisting cancers. Lack of effect on DCIS could...
  2. GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors.

    Cancer Res (2013) PMID 23650283

    We report the findings of a multidisciplinary strategy to address the impact of GDNF-RET signaling in the response to AI treatment. In breast cancer cells in 2D and 3D culture, GDNF-mediated RET signaling is enhanced in a model of AI resistance. Further, GDNF-RET signaling promoted the survival of A...
  3. Fracture Risk in Older, Long-Term Survivors of Early-Stage Breast Cancer.

    J Am Geriatr Soc (2013) PMID 23647433

    No difference was observed in fracture rates between groups (hazard ratio (HR) = 1.1, 95% confidence interval (CI) = 0.9-1.3). The protective effect of tamoxifen was not statistically significant (HR = 0.9, 95% CI = 0.6-1.2). CONCLUSION: Long-term survivors of early-stage breast cancer diagn...